Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB study.
Dagogo-Jack I, Cooper AJ, Johnson BE, Gainor JF, Lin JJ, Sequist LV, Piotrowska Z, Digumarthy SR, Mino-Kenudson M, Muzikansky A, Shaw AT. Dagogo-Jack I, et al. Among authors: lin jj. Lung Cancer. 2024 Nov 1;199:108003. doi: 10.1016/j.lungcan.2024.108003. Online ahead of print. Lung Cancer. 2024. PMID: 39615410
Brief Report: Final overall survival and long-term safety of lorlatinib in patients with ALK-positive non-small cell lung cancer from the pivotal phase 2 study.
Ignatius Ou SH, Solomon BJ, Besse B, Bearz A, Lin CC, Chiari R, Camidge DR, Lin JJ, Abbattista A, Toffalorio F, Soo RA. Ignatius Ou SH, et al. Among authors: lin jj. J Thorac Oncol. 2024 Nov 22:S1556-0864(24)02484-5. doi: 10.1016/j.jtho.2024.11.021. Online ahead of print. J Thorac Oncol. 2024. PMID: 39581380 Free article.
Phase II trial of consolidative stereotactic body radiation therapy in patients with metastatic oncogene-driven non-small cell lung carcinoma treated with tyrosine kinase inhibitors.
Keane FK, Yeap BY, Khandekar MJ, Lin JJ, Dagogo-Jack I, Sequist LV, Piotrowska Z, Willers H. Keane FK, et al. Among authors: lin jj. Int J Radiat Oncol Biol Phys. 2024 Nov 20:S0360-3016(24)03515-6. doi: 10.1016/j.ijrobp.2024.10.022. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39577475
The development of aperiodic neural activity in the human brain.
Cross ZR, Gray SM, Dede AJO, Rivera YM, Yin Q, Vahidi P, Rau EMB, Cyr C, Holubecki AM, Asano E, Lin JJ, McManus OK, Sattar S, Saez I, Girgis F, King-Stephens D, Weber PB, Laxer KD, Schuele SU, Rosenow JM, Wu JY, Lam SK, Raskin JS, Chang EF, Shaikhouni A, Brunner P, Roland JL, Braga RM, Knight RT, Ofen N, Johnson EL. Cross ZR, et al. Among authors: lin jj. bioRxiv [Preprint]. 2024 Nov 9:2024.11.08.622714. doi: 10.1101/2024.11.08.622714. bioRxiv. 2024. PMID: 39574667 Free PMC article. Preprint.
Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson's disease risk.
Chew EG, Liu Z, Li Z, Chung SJ, Lian MM, Tandiono M, Heng YJ, Ng EY, Tan LC, Chng WL, Tan TJ, Peh EK, Ho YS, Chen XY, Lim EY, Chang CH, Leong JJ, Peh TX, Chan LL, Chao Y, Au WL, Prakash KM, Lim JL, Tay YW, Mok V, Chan AY, Lin JJ, Jeon BS, Song K, Tham CC, Pang CP, Ahn J, Park KH, Wiggs JL, Aung T, Tan AH, Ahmad Annuar A, Makarious MB, Blauwendraat C, Nalls MA, Robak LA, Alcalay RN, Gan-Or Z, Reynolds R, Lim SY, Xia Y, Khor CC, Tan EK, Wang Z, Foo JN. Chew EG, et al. Among authors: lin jj. Nat Aging. 2024 Nov 21. doi: 10.1038/s43587-024-00760-7. Online ahead of print. Nat Aging. 2024. PMID: 39572736
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919].
Bauman JR, Liu G, Preeshagul I, Liu SV, Melosky B, Abrahami D, Li B, Thomaidou D, Duncan K, Krulewicz S, Rupp M, Lin JJ. Bauman JR, et al. Among authors: lin jj. Lung Cancer. 2024 Nov;197:108000. doi: 10.1016/j.lungcan.2024.108000. Epub 2024 Nov 2. Lung Cancer. 2024. PMID: 39488462 Free article. No abstract available.
1,808 results